Stock Report: Nanosphere Inc. (NSPH) Report Updated: May 13, 2013 | Print This Page
Report Features:
Stock Analysis
Rating: Monthly View
| A |  |
 |
|
 |
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | ||||||||||||
| C | ||||||||||||
| D | ||||||||||||
| F | ||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Rating: Weekly View
| This Week: | C  downgrade |
|---|---|
| Last Week: | B  no change |
| Two Weeks Ago: | B no change |
Company Profile
Nanosphere, Inc. develops, manufactures, and markets molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform. Its Verigene System includes a bench-top molecular diagnostics workstation with nanoparticle technology that provides the ability to run multiple tests simultaneously on the same sample. The Verigene System is used for testing infectious disease assays, human and pharmacogenetic assays, and ultra-sensitive protein assays. The company serves hospital-based laboratories and academic research institutions in the United States. Nanosphere, Inc. was founded in 1998 and is headquartered in Northbrook, Illinois.
Recent News: Nanosphere Inc.
| 2012-10-22 10:29:12 | Nanosphere Test Accurately Detects a Broad Panel of Bacterial Targets and Resistance Determinants Directly From Blood Culture |
| 2012-10-10 17:15:16 | Nanosphere, Inc. Appoints Roy N. Davis to Board of Directors |
| 2012-10-10 00:00:00 | Report of unscheduled material events or corporate changes - Form 8-K |
| 2012-10-10 00:00:00 | Initial statement of beneficial ownership of securities - Form 3 |
| 2012-10-02 00:00:00 | Pre-effective amendment to an S-3 filing - Form S-3/A |
My Portfolios (View All)
Save your portfolio—or a few for that matter—and check up on your stocks 24/7! Log in here.
Louis Navellier's Portfolios
- Blue Chip GrowthTop blue chips
- Emerging GrowthTop small-caps
- Ultimate GrowthFastest-moving
- Platinum GrowthElite Model Portfolio